ENVISAGE-TAVI-AF

Objective

The main purpose of this study is to gather information about a new oral anticoagulant that has been approved for in certain patients with atrial fibrillation and is not evaluated in patients after TAVI (Transcatheter Aortic Valve Implantation) that may help to treat your disease.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 09/05/2017

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Clinical Trials at 866-839-4128
or clinicaltrials@eirh.org